ARCHIVES

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

DCCP Board Oks Fur New Concepts

July 17, 1981

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009